Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CADU, a cloud-enabled AI solution created by Odin Vision, is designed to aid in identifying and characterizing dysplasia in individuals with Barrett’s oesophagus during gastroscopy. The system evaluates areas that visually resemble Barrett’s oesophagus and offers insights to help clinicians determine whether the tissue is dysplastic or non-dysplastic. By improving the decision-making process for endoscopists and expediting the examination of the oesophagus, CADU proves to be both time-efficient and cost-effective. Additionally, it functions on a platform that is vendor-neutral, facilitating its use with various endoscopic equipment. The system is CE marked and holds UKCA approval; however, it is not available for commercial sale in the United States. CADU has been adopted in clinical environments, including University College London Hospitals, aiming to enhance the detection of early oesophageal cancer, which can often be difficult to identify due to the subtle nature of initial lesions. Its implementation represents a significant advancement in the early diagnosis of this serious condition, highlighting the importance of technology in modern medicine.
Description
Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.
API Access
Has API
No
API Access
Has API
No
Integrations
Amazon Web Services (AWS)
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Odin Vision
Country
United Kingdom
Website
odin-vision.com/en_gb/cadu-2/
Vendor Details
Company Name
Qure.ai
Founded
2016
Country
United States
Website
www.qure.ai/product/lung-nodule-management
Product Features
Medical Imaging
Automated Routing
No
Comparison View
No
Compliance Management
No
Data Import / Export
No
Diagnostic Reporting
No
Image Analytics
No
Treatment Planning
No
Workflow Management
No
Product Features
Medical Imaging
Automated Routing
No
Comparison View
No
Compliance Management
No
Data Import / Export
No
Diagnostic Reporting
No
Image Analytics
No
Treatment Planning
No
Workflow Management
No